Share this article

What is Burkholderia pseudomallei?

Burkholderia pseudomallei is the bacteria that causes a rare and serious disease called melioidosis. It is listed alongside anthrax, bubonic plague, and smallpox as a high-priority biological agent that poses a risk to the public and national security.

B. pseudomallei is found in contaminated soil and water, and is endemic in areas of the world with tropical and sub-tropical climates. Cases of the disease in the United States are typically associated with travel to endemic areas.

However, in 2021, a multistate outbreak was identified in Georgia, Kansas, Minnesota, and Texas (CDC, https://www.cdc.gov/melioidosis/outbreak/2021/index.html, Accessed 9/8/2022), linked to an aromatherapy room spray imported from a country where the disease is endemic. This outbreak resulted in two fatalities.

More recently, B. pseudomallei was identified in water samples in the Gulf Coast region of Mississippi in 2022 (CDC, https://emergency.cdc.gov/han/2022/han00470.asp, Accessed 9/8/2022). B. pseudomallei is now considered locally endemic to that area as the environmental conditions of the Gulf Coast state are conducive to growth of this bacterium. The CDC is working with state partners to determine how widespread the bacteria is across the United States.

Signs and Symptoms of Melioidosis

Melioidosis has a wide range of signs and symptoms such as fever, joint pain, and headaches and can cause conditions that include pneumonia, abscess formation, or blood infections. As a result, it can be mistaken for other more common diseases. Worldwide, melioidosis is fatal in 10-50 percent of those infected. 

B. pseudomallei can lay dormant for decades. This was evident 20 years after the Vietnam War, when veterans experienced outbreaks into the 1990s.  

Clinicians should be aware of the signs and symptoms of melioidosis and consider it as a diagnosis in patients that present with symptoms of the disease.

Learn more about the signs and symptoms (CDC, https://www.cdc.gov/melioidosis/symptoms/index.html, Accessed 9/8/2022).

How Burkholderia pseudomallei Spreads

Burkholderia pseudomallei is spread to humans and animals through direct contact with the contaminated source. While person-to-person spread is extremely rare, health care workers caring for patients suspected or known to be infected with B. pseudomallei should follow standard precautions to prevent hospital-acquired infection (CDC, https://www.cdc.gov/infectioncontrol/basics/standard-precautions.html, Accessed 9/8/2022). B. pseudomallei is not considered to be transmitted person-to-person via air or respiratory droplets in non-laboratory settings. 

Learn more about transmission (CDC, https://www.cdc.gov/melioidosis/transmission/index.html, Accessed 9/8/2022).

Laboratory Acquired Infections

Laboratory personnel evaluating specimens or cultures from patients suspected of having melioidosis should exercise extreme caution as several cases of laboratory acquired infections have been documented.

Read how to manage an accidental laboratory exposure (CDC, https://www.cdc.gov/melioidosis/bioterrorism-response-planning/healthcare-response-activities.html#lab, Accessed 9/8/2022), which may require post-exposure prophylaxis to Burkholderia pseudomallei.

Laboratory Identification

Melioidosis is diagnosed by isolating Burkholderia pseudomallei from blood, urine, sputum, skin lesions, or abscesses; or by detecting an antibody response to the bacteria.

Characteristics of Burkholderia pseudomallei

  • It shows poor growth at 24-hours, good growth of smooth, creamy colonies at 48-hours on blood agar plates (BAP).

  • It may develop wrinkled colonies in time.

  • Is nonhemolytic.

  • Growth occurs on MacConkey Agar (MAC) in 48 hours.

  • Reactions are oxidase and tube catalase positive, indole negative, and tube motility positive.

Laboratory identification of B. pseudomallei can be difficult, especially in the U.S., where it is rarely seen: 

  • Colony morphology is variable and a single strain may display multiple colony types, so laboratory staff may mistakenly believe the growth is not pure.

  • The organism grows more slowly than other bacteria that may be present in clinical specimens.

  • It may easily be overgrown, especially in cultures from non-sterile sites.

Safety Considerations for Laboratory Testing

Laboratories testing for or handling cultures of Burkholderia pseudomallei should follow these laboratory practices, procedures, and safety protocols.

  • Use a Biological Safety Cabinet (BSC), either in a Biosafety Level 3 lab (BSL-3) or in a clinical lab setting using a Biosafety Level 2 lab (BSL-2) and BSL-3 precautions, when working with cultures.

  • Wear appropriate PPE, including an N95 mask, gloves, gown (tight wrists with tie in back), and goggles or face shield while working in a Biological Safety Cabinet.

  • Rule all poor growth or 48-hour growth in or out using the CDC’s Laboratory Response Network for Biological Threats (LRN-B) protocol prior to working up on automated systems.

  • Do not sniff plates.

  • Tape plates shut while incubating.

Warning

If a Gram negative rod is isolated in a Sentinel Laboratory and has no growth or slight growth on BAP and MacConkey agar at 24 hours, it should not be processed for identification by a multi-test kit or automated system, because of the danger of aerosol production due to preparing high concentrations of organisms. In addition, the identification by these systems can produce false results due to biochemically related organisms in the database.

As a nationally notifiable disease, melioidosis should always be reported to the state health department.

Additional Resources

Sentinel Level Clinical Laboratory Guidelines for Suspected Agents of Bioterrorism and Emerging Infectious Diseases (American Society for Microbiology)

Biosafety in Microbiological and Biomedical Laboratories (CDC)

About the Authors

Karie Brouillard, BS, ASCP, is the special pathogens laboratory coordinator at Providence Sacred Heart Medical Center & Children’s Hospital in Spokane, Washington. Prior to her role in the Special Pathogens Unit, Karie worked in the Microbiology department and as a point of care specialist in the Lab Regulatory and Safety department. Before joining the team at Sacred Heart, Karie was the bioterrorism coordinator for Eastern Washington and Northern Idaho of the Laboratory Response Network (LRN). She conducted trainings for sentinel laboratories and first responders on recognizing the agents of bioterrorism.

 

Vicki Herrera, MS, has worked in the clinical laboratory for the past 18 years. She is currently working as a research coordinator at the University of Nebraska Medical Center (UNMC) in the field of infectious diseases and bioaerosols. In addition, she supports both NETEC and the Nebraska Biocontainment Unit laboratory by providing education and training to laboratory staff. Previous work included a supervisor position at the Nebraska Public Health Laboratory (NPHL) in the Molecular and Microbiology sections, including the LRN laboratory.

 

Karen Stiles, BS, BA, is the state training coordinator at Nebraska Public Health Laboratory (NPHL). She has 25 years of experience as a medical technologist in microbiology, and specializes in laboratory biological and chemical preparedness, and LRN sentinel guidelines.

Get Expert Assistance

Ask a NETEC expert a question or request free services for your facility.

Find Resources

Explore special pathogen resources created and curated by NETEC experts.

Stay Informed

Sign up for the NETEC e-newsletter to stay up to date on resources and news.

Ebola: NETEC has compiled clinical guidance, preparedness resources, and educational materials related to ebola to support healthcare professionals and healthcare teams seeking reliable, evidence-informed information.
Access the resource library here.

Close Welcome Bar